$44 Million Chantix Settlement Reached in Class Action Lawsuit
A $44 million settlement has been reached in a class action lawsuit against Pfizer, Inc. (Pfizer) over allegations that its drug Chantix contained an undisclosed nitrosamine between September 29, 2015 and September 17, 2021. The case was settled to avoid ongoing litigation costs; the court has not ruled on liability.
Tickers: $PFE
Topics: lawsuit pharmaceuticals settlement